REGISTER now for FREE 
|
FREE patent keyword monitoring and additional FREE benefits. REGISTER now for FREE
|
|
|
Drug, Bio-affecting And Body Treating Compositions > Designated Organic Active Ingredient Containing (doai) > Nitrogen Containing Other Than Solely As A Nitrogen In An Inorganic Ion Of An Addition Salt, A Nitro Or A Nitroso Doai > Benzene Ring Containing > Amino Nitrogen Attached To Aryl Ring Or Aryl Ring System By An Acyclic Carbon Or Acyclic Chain Amino Nitrogen Attached To Aryl Ring Or Aryl Ring System By An Acyclic Carbon Or Acyclic ChainAmino Nitrogen Attached To Aryl Ring Or Aryl Ring System By An Acyclic Carbon Or Acyclic Chain patent applications listed are from June 2005 to current and include Date, Patent Application Number, Patent Title, Patent Abstract summary and are linked to the corresponding patent application page.12/07/06 - 20060276549 - Combination and use of drugs The present invention is directed to preferred pharmaceutical compositions comprising sibutramine and rimonabant and use of sibutramine and rimonabant to treat obesity and obesity related disorders in a patient. ... 11/23/06 - 20060264515 - Compounds, formulations, and methods for ameliorating telangiectasias Methods, compounds, and topical formulations for treatment of telangiectasias are disclosed. The methods comprise topically applying a composition comprising an α-adrenergic receptor agonist to telangiectatic skin. Amelioration of telangiectasia symptoms begins within minutes after topical application of a disclosed composition. A single application can significantly lessen telangiectasia discoloration for at ... 10/05/06 - 20060223891 - Use of alverine, alone or in combination with a tricyclic antidepressant or an antidepressant which is a specific inhibitor of serotonin reuptake for treatment of depression The present invention relates to the utilisation of Alverine or its metabolites, alone or in combination with a tricyclic antidepressant or a specific inhibitor antidepressant of serotonin recapture, for the preparation of pharmaceutical compositions for the treatment of depression. ... 09/14/06 - 20060205821 - Enantiomers of n-desmethyl venlafaxine The present invention provides enantiomers of N-Desmethyl venlafaxine, as well as their use in pharmaceutical compositions and medically useful treatments, particularly including central nervous system uses. ... 09/07/06 - 20060199867 - Ambroxol for the treatment of chronic pain The invention relates to the use of ambroxol and the pharmacologically acceptable salts thereof for preparing a pharmaceutical composition for the treatment of diseases which are based on a powerful activation of voltage-dependent sodium channels, particularly for the treatment of chronic pain. ... 09/07/06 - 20060199866 - Combination of desoxypeganine and mecamylanine for the treatment of alcohol abuse An active substance combination comprising deoxypeganine or of one of its pharmaceutically acceptable derivatives and mecamylamine or one of its pharmaceutically acceptable derivatives. The active substance combination serves to produce a medicament for the treatment of alcohol abuse and/or alcohol dependence. ... 08/24/06 - 20060189698 - Treatment of interstitial cystitis The present invention relates to compositions and methods of alleviating a symptom of chronic pelvic pain syndrome with an amphetamine. Specifically, the invention includes a method of administering dextroamphetamine or a salt thereof to an animal in order to treat interstitial cystitis, vulvovaginits and/or vulvodynia. The invention also includes a ... 08/17/06 - 20060183805 - Non-oxidatively metabolized compounds and compositions, synthetic pathways therefor, and uses thereof The subject invention provides therapeutically useful and therapeutically effective compounds and compositions for the treatment of a variety of disorders. The compounds of the invention exhibit significantly reduced levels of drug-drug interactions (DDI) and are metabolized, primarily, via non-oxidative systems. ... 08/03/06 - 20060173080 - Methods of modulating tnf using bupropion A new method employing a known compound, bupropion hydrochloride (.±.)-1-(3-chlorophenyl)-2-[(1,1-dimethylethyl)amino]-1-propanone hydrochloride, and its analogues, in a new use for the treatment of TNF-related disorders is described. ... 07/27/06 - 20060167112 - Methods and compositions for regulating memory consolidation The present invention makes available methods and reagents for enhancing and/or restoring long-term memory function and performance. ... 07/27/06 - 20060167111 - Methods for treating an impairment in memory consolidation Impairments in memory consolidation are treated with an amphetamine compound. In one embodiment, the method includes administering an l-amphetamine compound. In another embodiment, the method includes administering an l-methamphetamine compound. The method can include determining memory consolidation before, during and/or after administering the amphetamine compound. ... 07/27/06 - 20060167110 - Methods for treating cerebrovascular disease by administering desmethylselegiline The present disclosure is directed to methods for reducing the neuronal damage associated with cerebrovascular disease, such as stroke or cerebral edema, by administering R(−)-desmethylselegiline, S(+) desmethylselegiline, or a combination of the two. The cerebrovascular disease may be caused by ischemia or hypoxia. ... 07/27/06 - 20060167109 - Methods of reducing rhinovirus contagion and related compositions The present invention relates to the use of pleconaril to reduce the contagion of rhinovirus virions shed from a host infected with a rhinovirus and thereby reduce disease transmission or re-infection. ... 07/20/06 - 20060160905 - Compositions and methods for inhibiting pain R and R1 are the same or different and may be H or linear or branched chain alkyl having 1 to 8 carbon atoms, m is an integer from 0 to 10, inclusive and wherein the amine exhibits a mean reduction in abdominal writhings exhibited by mice in the standard ... 07/13/06 - 20060154991 - Inhibitors of candida albicans The invention provides methods for identifying modulators of yeast phenotypic transitions and methods for treating fungal infections with modulators of phenotypic transitions of yeast cells. These methods include methods for identifying inhibitors of the budded-to-hyphal transition of Candida albicans and methods for treating fungal infections with inhibitors of the budded-to-hyphal ... 07/06/06 - 20060148904 - Anti tubercular drug: compositions and methods Methods and compositions for treating disease caused by infectious agents, particularly tuberculosis. In particular, methods and compositions comprising substituted ethylene diamines for the treatment of infectious diseases are provided. In one embodiment, these methods and compositions are used for the treatment of mycobacterial infections, including, but not limited to, tuberculosis. ... 06/22/06 - 20060135622 - Amino alcohol derivative, addition salt thereof, and immunosuppressant An amino alcohol derivative represented by the following general formula (1) (for example, (±)-2-amino-5-[4-(3-benzyloxyphenylthio)-2-chlorophenyl]-2-methylpentane-1-ol) exhibits strong immunosuppressive effect while causing less side effects: ... 05/25/06 - 20060111448 - Methods for treating cognitive impairment in humans with multiple sclerosis Cognitive impairments in humans with multiple sclerosis are treated and cognition is improved with an amphetamine compound. In one embodiment, the method includes administering an l-amphetamine compound. In another embodiment, the method includes administering an l-methamphetamine compound. ... 04/06/06 - 20060074131 - Novel crystalline polymorph of venlafaxine hydrochloride and methods for the preparation thereof This invention relates to a highly thermally stable novel anhydrous crystalline polymorphic form of venlafaxine hydrochloride, methods for the preparation thereof, and its use. ... 03/30/06 - 20060069164 - Process for preparing terbinafine by using platinum as catalyst A process for the preparation of terbinafine, comprising the reaction of a compound of formula (II), or a salt thereof, wherein X is a leaving group, with tert-butylacetylene, in the presence of a platinum catalyst. ... 03/02/06 - 20060047007 - Method for treating urinary disorders The present invention relates to a method, preferable an oral method, for treating urinary disorders, such as unstable or overactive bladder, while minimizing the occurrences of dry mouth, dyspepsia and reduced stream of tears. The methods of the present invention comprise orally administering to a mammal, preferably a human, a ... 02/16/06 - 20060035980 - Thyronamine derivatives and analogs and methods of use thereof Thyronamine derivatives and analogs, methods of using such compounds, and pharmaceutical compositions containing them are disclosed. Methods of preparing such compounds are also disclosed. ... 01/26/06 - 20060020041 - Anti tubercular drug: compositions and methods Methods and compositions for treating disease caused by infectious agents, particularly tuberculosis. In particular, methods and compositions comprising substituted ethylene diamines for the treatment of infectious diseases are provided. In one embodiment, these methods and compositions are used for the treatment of mycobacterial infections, including, but not limited to, tuberculosis. ... 01/26/06 - 20060020040 - Bupropion hydrochloride solid dosage forms The present invention relates to solid dosage forms that contain bupropion hydrochloride and glucono delta lactone or its corresponding open chain hydroxy acid derivative. The bupropion hydrochloride retains at least 80% of the bupropion hydrochloride potency after storage for three months at 40° C. and 75% relative humidity. The solid ... 01/19/06 - 20060014838 - Process for converting trans-sertraline to cis-sertraline A process for preparing sertraline hydrochloride includes reacting trans-N-methyl-4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydro-1-napthaleneamine with a base in an aqueous basic organic solvent. ... 12/29/05 - 20050288377 - Use of calcimimetic as an adynamic bone disease related treatment The present invention relates to monitoring and treatment of adynamic bone disease and related disorders and the consequences of thereof. In one aspect, the present invention is directed to a method for avoiding or reducing soft tissue calcification (or the risk thereof) in a subject afflicted with adynamic bone disease, ... 12/15/05 - 20050277697 - Method for treatment of the common cold, flu, and virus symptoms This invention relates to the treatment of a person exhibiting the effects of a flu-like or viral infection. The method includes treating the person with an amphetamine, amphetamine derivative, or a salt thereof in an amount effective to alleviate the adverse symptoms resulting from the flu-like or viral infection. ... 12/08/05 - 20050272821 - Levalbuterol hydrochloride polymorph a The invention is directed to processes for making levalbuterol HCl Polymorph A from by suspending or forming a first slurry of (R)-SLB(D)-DBTA in at least a first organic solvent, adding HCl to the suspension or slurry of the solid (R)-SLB.D-DBTA until the (R)-SLB.D-DBTA forms levalbuterol HCl Polymorph A, and isolating ... 11/24/05 - 20050261376 - Process for the synthesis of (is)-4,5-dimethoxy-1-(methylaminomethyl)-benzocyclobutane and addition salts thereof, and to the application thereof in the synthesis of ivabradine and addition salts thereof with a pharmaceutically acceptable acid Application in the synthesis of ivabradine, addition salts thereof with a pharmaceutically acceptable acid, and hydrates thereof. ... 11/17/05 - 20050256204 - Topical phenyl-epinephrine rosacea treatment A near-permanent skin treatment includes photothermolysis of reddened facial skin to induce ischemia. Reperfusion of the photothermolysis treated skin is inhibited by following with regular applications of phenyl-epinephrine carried in a lotion until vascular necrosis is complete. Alternatively, a temporary treatment for reddened facial skin includes only cosmetic as-needed applications ... 11/03/05 - 20050245617 - Methods and compositions for the treatment of cns-related conditions The invention provides methods and compositions for the treatment of dementia-related conditions, such as Parkinson's disease and Alzheimer's disease. ... 10/06/05 - 20050222269 - Use of deprenyl compounds to treat viral infections and reduce tissue damage associated therewith Methods for treating viral infections are disclosed. The methods of the invention are useful for inhibiting viral infection in a subject and for preventing reducing tissue damage associated with viral infections. The method can include the step of administering to a subject in need thereof a therapeutically effective amount of ... 09/22/05 - 20050209339 - Methods for the treatment of sinusitis The invention provides a method of treating chronic rhinosinusitis such as allergic fungal sinusitis comprising daily oral administration of a composition from more than 500 mg to about 800 mg, preferably about 625 mg or 725 mg terbinafine base equivalent as hydrochloride, or a molar equivalent in other acid addition ... 09/15/05 - 20050203190 - Methods of treating gastrointestinal tract disorders using sodium channel modulators The invention relates to methods of using sodium channel modulators, particularly TTX-R sodium channel modulators and/or activity dependent sodium channel modulators to treat a gastrointestinal tract disorders, particularly inflammatory bowel disorders and irritable bowel syndrome. ... 08/18/05 - 20050182141 - Therapeutic agents Substituted cycloalkyl compounds with 3 to 6 carbon atoms in the ring, one carbon linked to each of two side groups R and R′, and pharmaceutically acceptable salts thereof in which R is phenyl optionally substituted by one or more halo substituents or R is naphthyl; and R′ is —[X—Y—S(O)m-Z-N—R1—R2], ... 07/28/05 - 20050165115 - Methods and compositions for predicting compliance with an antidepressant treatment regimen Methods and compositions are provided for predicting whether a subject will comply with an antidepressant treatment regimen. In practicing the subject methods, a subject's serotonin transporter gene-linked polymorphic region (5HTTLPR) is genotyped. Based on the identified genotype, a particular antidepressant treatment regimen suitable for the patient is determined. Also provided ... 06/30/05 - 20050143471 - Taste masking spill-resistant formulation The invention relates to a spill-resistant pharmaceutical composition, comprising a spill-resistant formulation with taste masking concentrations of polyethylene glycol (PEG) and diphenhydramine, which is less bitter, sweeter and has better overall flavor than current pharmaceutical compositions, while maintaining advantageous spill-resistant properties. ... 06/16/05 - 20050131073 - Enantiomerically enriched 1-phenylethylamines The present invention relates to a process for preparing nitro-substituted, enantiomerically enriched 1-phenylethylamines, and to their use. ... ### FreshPatents.com Support |